Found 1005 matching trials
Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies PHASE1 The primary purpose of this study is to determine the safety and efficacy o...
Show More Location
The Affiliated People's Hospital of Ningbo University
Learn More & Join Trial
A Combination Study of CAR-T Therapy in r/r B-NHL PHASE2 In registry studies of CAR-T products that have been marketed globally, pat...
Show More Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Learn More & Join Trial
Study of IFN-α Combined With CAR-T Cell Therapy in Relapsed and Refractory Acute Lymphoblastic Leukemia(R/R-ALL) PHASE2 The purpose of this study is to evaluate the safety and efficacy of IFN-α c...
Show More Location
The First Affiliated Hospital of Soochow University
Learn More & Join Trial
Clinical Study of Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of Relapsed/Refractory Non-Hodgkin Lymphoma PHASE1 This is a phase I clinical study to evaluate the safety and efficacy of CAR...
Show More Location
Shandong Second Provincial General Hospital
Learn More & Join Trial
Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso PHASE1 RATIONALE: Placing a tumor antigen chimeric receptor that has been created ...
Show More Location
Biotherapeutic Department and Pediatrics Department of Chinese PLA General Hospital
Learn More & Join Trial
CD4 CAR+ ZFN-modified T Cells in HIV Therapy PHASE1 This research study is being carried out to study a new way to possibly tre...
Show More Status
Active Not Recruiting
Location
University of Pennsylvania
Learn More & Join Trial
Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Autoimmune Diseases PHASE1 The goal of this study is to evaluate the safety and efficacy of CD19 CAR T...
Show More Location
Henan Province Engineering Technology Research Center of Immunological Precision Medicine and Artificial Intelligence Application, The Second Affiliated Hospital of Henan University of Science and Technology, Luoyang, China
Learn More & Join Trial
Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases PHASE1 The CATARSIS study explores the use of anti-CD19 CAR T-cell therapy as a no...
Show More Location
Fondazione Policlinico Universitario A. Gemelli IRCCS
Learn More & Join Trial
A Study of CCT301-59 CAR T Therapy in Adult Subjects With Recurrent or Refractory Solid Tumors PHASE1 This clinical study is to investigate the safety and tolerability of CAR mo...
Show More Location
Shanghai Zhongshan Hospital
Learn More & Join Trial
Safety and Efficacy of GYA01 (CART84) in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Acute Lymphoblastic T Leukemia Patients (T-ALL). PHASE1 This Phase I/IIa clinical study is testing an experimental treatment called...
Show More Location
Hospital Clínic de Barcelona
Learn More & Join Trial